 |
INTRODUCTION |
Oxidation of low density lipoprotein
(LDL)1 in the arterial intima
is believed to play a key role in atherogenesis (1, 2). It is likely
that the cells present in the arterial wall and developing lesions
participate in the oxidative process (1, 3). The mechanisms by which
these cells promote lipoprotein oxidation are of great interest and
have been investigated in numerous studies (4), as they could be
potential targets for therapeutic or preventative intervention in the
disease process. In addition to pro-oxidant action of cells toward LDL,
it has been demonstrated that under certain conditions the cells could
have potential antioxidant activity toward the lipoprotein. For
example, in some situations macrophages could inhibit metal-catalyzed
lipid peroxidation (5, 6) by sequestering metals from the culture
medium. Endothelial cells have also been shown to prevent formation of
lipid hydroperoxides in LDL (7); this activity switched to a
pro-oxidant action of the cells upon increasing the initial
concentrations of hydroperoxides in LDL or metal ions in media. A
potential protective role has been demonstrated for human hepatic
cells, which selectively take up and detoxify cholesteryl ester
hydroperoxides from high density lipoprotein particles (8). We have
previously reported the capacity of murine macrophages to remove
peroxides rapidly from oxidized amino acids, peptides, and proteins
(9). In the case of the oxidized proteins at least, this process was
likely to be extracellular, as it was not accompanied by significant
net uptake of the protein molecules. In the present study, we
demonstrated the ability of cells to extracellularly detoxify
cholesteryl ester hydroperoxides in LDL in a culture medium that did
not support cell-mediated LDL oxidation, and we studied possible
mechanisms of this process. We also tested different cell types for
their ability to reduce levels of lipid hydroperoxides in lipoprotein and regulation of this process.
 |
MATERIALS AND METHODS |
Chemicals and Reagents--
RPMI 1640, Hanks' balanced salt
solution (HBSS, phenol red-free), phosphate-buffered saline (PBS),
bovine serum albumin (BSA) (Fraction V), d-
-tocopherol,
bathocuproine disulfonic acid (BCS), trypsin, and
diethylenetriaminepentaacetic acid (DETAPAC) were purchased from Sigma.
Fetal calf serum (FCS) was obtained from Life Technologies, Inc. White
cell concentrate (<24 h ex vivo) and human serum (HS) were
kindly provided by the New South Wales Red Cross Blood Transfusion
Service, Sydney, Australia. Both FCS and HS were heat-inactivated at
56 °C for 30 min. Dulbecco's minimum essential medium (DMEM) was
from Trace BioSciences. EDTA, sodium borohydride (NaBH4),
and potassium bromide (KBr) were from BDH, chloramphenicol was from
Roche Molecular Biochemicals, and NaCN was from Merck.
2,2'-Azo-bis(2-amidinopropane)hydrochloride (AAPH) was from
Polysciences, desferal (desferrioxamine mesylate, DF) was purchased
from Ciba-Geigy (Pendle Hill, New South Wales, Australia). Nanopure
water was used for preparation of all aqueous buffers. PBS was
subsequently treated with washed Chelex 100 resin (Bio-Rad) to remove
contaminating amounts of transition metals (10). PD-10 columns
prepacked with Sephadex G-25 (Medium) were obtained from Amersham
Pharmacia Biotech. HPLC-grade hexane, methanol, and isopropyl alcohol
were from Mallinckrodt or EM Science, and ethanol (analytical grade)
was from BDH. All other chemicals used were of the highest purity available.
Cell Culture--
Resident macrophages (MPM) were isolated from
6-week-old Quackenbush Swiss strain mice, after CO2
asphyxiation, by peritoneal lavage with ice-cold DMEM, containing
0.38% (w/v) sodium citrate, penicillin G (100 units/ml), and
streptomycin (100 µg/ml). The isolated cells were immediately plated
in 12-well (22-mm diameter) cell culture plates (Falcon) at 4 × 106 cells per well or at the indicated density for cell
number dependence experiments. The cells were incubated at 37 °C for
2 h and then washed three times with PBS to remove non-adherent
cells. The cells were further incubated in DMEM containing 10% FCS for
18 h.
J774 A.1 mouse monocyte-macrophage cells (J774, obtained from the
American Type Culture Collection, batch F-10089) were grown in DMEM
containing 10% (v/v) FCS in 160-cm2 cell culture flasks
(Becton Dickinson). Cells were subcultured at 1:5 dilution every 6-7
days. The day before an experiment the cells were plated in 6-well
(35-mm diameter) cell culture plates (Falcon) at 2.5 × 106 cells per well.
Human monocytes were isolated from white cell concentrates using
centrifugal elutriation as described previously (11). Purified monocytes (>90% pure as judged by nonspecific esterase staining) were
adhered in 22-mm cell culture wells (Falcon) at 4 × 106 cells per well and cultured in RPMI 1640 containing
10% (v/v) HS for 7 days to allow them to differentiate to macrophages.
The cells were cultured in a humidified incubator at 37 °C in 5%
CO2 in air. All tissue culture media were supplemented with 20 mM glutamine, 100 units/ml penicillin G, and 100 µg/ml
streptomycin. Cell viability was assessed by the trypan blue exclusion
test. Prior to experiments cells were washed twice with warm PBS.
Preparation of Cell-conditioned Medium, Separation of High and
Low Molecular Weight Fractions of Cell-conditioned Medium--
1-ml
portions of DMEM were added to cells and incubated for 2.5 h at
37 °C in 5% CO2 in air. The medium pooled from several cell culture wells was spun (1,000 × g, 5 min,
5 °C) to remove any detached cells, and the supernatant was used as
the cell-conditioned medium.
In some experiments 2 ml of cell-conditioned medium was spun in a
Centricon-10 concentration unit (Amicon) at 4,900 × g
and 4 °C for 45 min, and then the high and low molecular weight
fractions (retentate and filtrate, respectively) were reconstituted to
the original volume with DMEM. Separation of high and low molecular weight components using filtration through a PD-10 column is described in detail in the legend to Fig. 3.
Preparation of LDL--
LDL (density range 1.02-1.05) was
prepared from plasma from fasted normolipidemic healthy volunteers as
described in detail (12) by density gradient ultracentrifugation
(Beckman L8-M ultracentrifuge) using a vertical (VTi50) rotor for
2.5 h at 242,000 × g (mean) and 10 °C. A
second centrifugation at a density of 1.063 g/ml with Ti70 rotor
(242,000 × g (mean), 22 h, 10 °C) removed
traces of contaminating albumin. The LDL was subsequently dialyzed for 18 h at 4 °C against 4 × 1 liter of deoxygenated PBS
containing chloramphenicol (0.1 g/liter) and EDTA (1.0 g/liter),
filter-sterilized (0.45-µm), and stored in the dark at 4 °C until
use (within 7 days). Immediately prior to oxidation or incubation with
cells, LDL was passed through two consecutive PD-10 columns
equilibrated with Chelex 100-treated PBS to remove EDTA. LDL was
further sterilized (0.45-µm filter) for cellular experiments.
Mild Oxidation of LDL, in Vitro Preparation of Mildly Oxidized
-TOH-depleted LDL--
An aliquot of LDL (in the range of 2-4 mg
of LDL protein/ml) was incubated with 1 mM AAPH at 37 °C
for approximately 1 h. Under these conditions of low radical flux,
oxidation of LDL resulted in formation of small amounts of lipid
hydroperoxides with a less than 10% loss of
-tocopherol (
-TOH)
and no changes in protein and lipid composition (13, 14). AAPH was
removed by two sequential PD-10 column filtrations. The mildly oxidized
LDL used in experiments in this study contained 28.5 ± 12.5 nmol
CEOOH per mg of LDL protein (mean ± S.D., n = 25)
with TOH content being 8.2 ± 3.9 nmol/mg (mean ± S.D.,
n = 25).
Oxidized
-TOH-depleted LDL was prepared as described in detail (13).
LDL (~2-4 mg/ml) was oxidized with 50 mM AAPH at
37 °C for 20-30 min. AAPH was removed by two sequential gel
filtrations using the PD-10 columns. The resulting LDL contained
undetectable levels of
-TOH and cholesteryl ester hydroperoxides at
levels comparable to that reached in mildly oxidized TOH-containing LDL (prepared as above). Oxidized
-TOH-depleted LDL was without other significant detectable changes in lipid composition (13).
In Vitro Replenishment of TOH-depleted LDL with
-TOH--
TOH-depleted LDL prepared as above was replenished with
-TOH as described (13). In detail, an aliquot of TOH-depleted LDL was incubated with lipoprotein-deficient serum (LPDS) (2:1, v/v) supplemented with
-TOH (dissolved in Me2SO (15), final
concentration of Me2SO <1%) at 37 °C for 4 h.
LPDS was prepared from plasma from fasted normolipidemic healthy
volunteers (16) and contained no detectable levels of
-TOH. The
final concentration of
-TOH in the incubation mixture was seven
times that of the corresponding native unoxidized LDL. Control mildly
oxidized and control TOH-depleted LDL were incubated with LPDS in the
presence of Me2SO (<1%, v/v). After incubation the
density of the mixture was adjusted with KBr to 1.21, and LDL was then
reisolated using a quick LDL isolation method (17) with a 3.5-h
centrifugation. The LDL was passed through two consecutive PD-10
columns, filter-sterilized, and used immediately.
Incubation of LDL with Cells--
1-ml portions of DMEM (or
1.5-ml for J774 cultures) containing 100 µg of LDL protein were
incubated in cell culture wells at 37 °C in 5% CO2 in
air with or without cells. In experiments using cell-conditioned
medium, 1 ml of this was mixed with 100 µg of LDL and incubated in
cell-free wells under the above conditions.
Lipid Extraction--
At the times indicated, the LDL-containing
media were removed from the cell culture wells and spun in an Eppendorf
centrifuge at 16,000 × g for 2 min at 4 °C to
remove any detached cells. 0.5 ml of the supernatant (or cell-free
medium) was extracted with 1 ml of cold methanol and 5 ml of hexane and
then centrifuged (1,000 × g, 5 min, 10 °C). 4 ml of
the hexane phase were withdrawn, evaporated under vacuum, and
redissolved in 200 µl of isopropyl alcohol. Samples were sealed in
glass vials and stored at
80 °C until HPLC analysis (within 7 days). Recovery of
-TOH and lipid in the extracts was
99%;
-TOH, cholesteryl esters (CE) and their hydroperoxides (CEOOH) were
stable under this condition for at least 6 weeks (data not shown).
In experiments where cellular lipid analysis was carried out, the cells
were washed three times with warm PBS, and the cell lipids were
extracted twice with 1 ml of hexane/isopropyl alcohol (3:2, v/v) (12).
The cells were then lysed by incubation in 0.5 ml of cold 0.2 M NaOH for 15 min at 4 °C, and the lysates were stored
at
20 °C for protein assay (within 7 days).
HPLC Analysis--
Lipid extracts from cells or LDL-containing
media were analyzed using reverse phase-high performance liquid
chromatography (RP-HPLC) with a Supelco ODS column (25 × 0.46 cm,
5 µM particle size with a 2-cm Pelliguard guard column)
as described (18) using a mobile phase of ethanol/methanol/isopropyl
alcohol (19.5:6:1, v/v/v) containing 5 mM lithium
perchlorate. Analysis was performed using electrochemical or
fluorescent detection (for
-TOH, with
0.1 pmol and pmol detection
limit, respectively), UV210 (for free cholesterol (FC) and
cholesteryl esters (CE) detection), or UV234 (for oxidized
products of CE) detection. Cholesteryl ester hydroperoxides (CEOOH)
were analyzed by post-column chemiluminescence (CL) detection
(detection limit
1-5 pmol). In some experiments, HPLC analysis was
performed as in Kritharides, et al. (19) with separation of
CEOOH and cholesterol ester hydroxides (CEOH) peaks. In brief, the
lipids were separated on an ODS column using acetonitrile/isopropyl alcohol/water (44:54:2, v/v/v) as a mobile phase with UV210
detection for unoxidized FC and CE, UV234 detection for
CEOOH and CEOH, and UV279 for cholesteryl
keto-octadecadienoate (CE=O). Analysis of tocopherylquinone was
performed by HPLC with electrochemical detection as described (20); the
response factor was 34,187 area units per pmol of
tocopherylquinone.2
Quantitation of FC, individual CEs, and
-TOH was performed using calibration curves for each of the commercially available compounds. CEOOH were quantified using a cholesteryl linoleate hydroperoxide standard prepared as described previously (17, 21). The concentration of CEOH was calculated using a cholesteryl linoleate hydroxide standard
prepared by reduction of corresponding hydroperoxide standard with
NaBH4.
Preparation of the Radiolabeled Ch18:2-OOH and Its Incorporation
into Liposomes--
[3H]Cholesteryl linoleate
hydroperoxide ([3H]Ch18:2-OOH) was prepared from
[1a,2a-3H]cholesteryl linoleate
([3H]Ch18:2; Amersham Pharmacia Biotech, specific
activity 45 Ci/mmol) by the method previously described (8) with small
modifications. Briefly, 200 µCi of [3H]Ch18:2 dissolved
in 200 µl of toluene was oxidized at 60 °C for 5 h using 403 mM 2,2'-azo-bis(2,4-dimethylvaleronitrile) (Polyscience, Warrington, PA). Following oxidation, non-oxidized tracer was separated
from [3H]Ch18:2-OOH using an
Al2O3 solid phase extraction column as
described (8). The isolated [3H]Ch18:2-OOH was further
purified by RP-HPLC using isopropyl alcohol/acetonitrile/water (44:54:2, v/v/v) mobile phase (19) with UV234 and on-line
radiometric detection (Radiomatic Flo-One Beta detector, Packard
Instrument Co.) using Ultima-FLQ M scintillation mixture at 1.5 ml/min.
The activity eluting between 12.6 and 15 min (i.e. retention
time of Ch18:2-OOH standard) was collected, dried under argon, and redissolved in isopropyl alcohol. The purified
[3H]Ch18:2-OOH (specific radioactivity 1.5 Ci/mmol) was
quantified using RP-HPLC with post-column CL detection as described
(18) with Ch18:2-OOH as a standard.
To prepare unilamellar liposomes aliquots of stock solutions of
DL-
-phosphatidylcholine dimyristoyl (DMPC), FC,
-TOH,
Ch18:2-OOH, and [3H]Ch18:2-OOH were mixed, the organic
solvent was evaporated under vacuum, and the lipids were resuspended in
PBS. 1 ml of the lipid emulsion contained 0.2 mg of DMPC, 120 nmol of
FC, 20 nmol of
-TOH, 30 nmol of Ch18:2-OOH, and 1.5 µCi of
[3H]Ch18:2-OOH; the concentrations of
-TOH and
Ch18:2-OOH in the liposome preparation were chosen to achieve levels
similar to those in the experiments with LDL. The mixture was mixed
vigorously, and the emulsion was sonicated in three 1-min cycles on ice
(Branson Sonifier 450). The resultant unilamellar liposomes were
sterilized (0.45-µm filter) and used within 1 h.
In the experiments with cell-conditioned medium an aliquot of liposomes
was mixed with the cell-conditioned medium from MPM (1:10 dilution) and
incubated for 2.5 h at 37 °C. The lipids were then extracted as
above and analyzed using RP-HPLC with UV234 and radiometric
detection and isopropyl alcohol/acetonitrile/water mobile phase (see
above). The 3H-labeled tracers were identified by comparing
their retention times with those of known, unlabeled standards and of
purified [3H]Ch18:2-OOH. To assess the total
radioactivity in each sample, 50-µl aliquots of methanol and hexane
layers of the lipid extracts were mixed with Ultima Gold HFP
scintillation mixture and quantified on Liquid Scintillation Analyzer
Tri-carb 2100TR (Packard Instrument Co.). More than 99.2% of the total
radioactivity in each analyzed sample was detected in the hexane layer
of the lipid extract, and further analysis of the methanol layer was
not performed. To measure the concentrations of
-TOH, FC, and
Ch18:2=O in a sample, an aliquot of each lipid extract was also
subjected to a separate RP-HPLC run using identical chromatographic
conditions with fluorescent (for TOH), UV210 (for FC), and
UV279 (for Ch18:2=O) detection.
Measurement of Copper Release by Macrophages--
MPM (7 × 106 cells per 35-mm well in 6-well plate) were washed three
times with PBS (37 °C) and subsequently incubated at 37 °C in 1.5 ml of HBSS containing 125 µM BCS and 100 µM
ascorbate for 3 h. This had no effect on cell viability (22).
Parallel control incubations were performed in the absence of cells.
The culture supernatants were removed and centrifuged to remove any cells, and their absorbance was measured at 482 nm. In some experiments the cells were incubated for 3 h in 1.5 ml of HBSS, lacking either ascorbate or BCS, or both of them. After the supernatants were removed
and spun, these reagents were added to make the medium complete,
i.e. containing 100 µM ascorbate and 125 µM BCS. The concentration of copper was calculated using
an extinction coefficient
= 12.15 mM
1 cm
1 for the BCS·Cu(I)
complex (22). Three separate wells were used for each condition in
three independent experiments.
Protein Assay--
The protein content of LDL samples and cell
lysates was measured using the bicinchoninic acid method (Sigma) with
BSA as a standard. BSA standards were prepared in water or in 0.2 M NaOH for the LDL preparations or cell extracts,
respectively. The samples were incubated for 60 min at 60 °C, and
the absorbance at 562 nm was measured.
 |
RESULTS |
Time and Cell Number Dependence of LDL Cholesteryl Ester
Hydroperoxides Degradation by Mouse Peritoneal
Macrophages--
Incubation of MPM with LDL (100 µg/ml) containing
modest levels of CEOOH (28.5 ± 12.5 nmol/mg LDL protein,
mean ± S.D. from 25 independent LDL preparations) in DMEM, the
medium non-permissive for LDL oxidation, resulted in a
time-dependent loss of CEOOH in LDL (Fig.
1A). In the same medium the
level of CEOOH remained stable in LDL incubated in cell-free wells
(Fig. 1A). The levels of free cholesterol and cholesteryl
esters in the medium remained unchanged during incubation of cells with
LDL under these conditions (not shown). This indicates that the
observed loss of CEOOH in LDL was not likely to be due to the whole LDL
particle uptake by cells or to continuing lipid peroxidation. When LDL
was incubated with cells plated at different densities, the decrease in
CEOOH concentration occurred at different rates, with higher rate
corresponding to the higher cell number condition (not shown). This
resulted in the different amounts of CEOOH remaining in LDL at the end of incubation (Fig. 1B). Parallel to reduction of CEOOH
level, incubation of MPM with LDL in DMEM resulted in a decrease in the concentration of TOH in LDL (Fig. 1C), whereas no
significant loss of TOH was observed in cell-free conditions (Fig.
1C). Loss of TOH in LDL also occurred in cell number- (Fig.
1D) and time-dependent manner. No detectable
amounts of tocopherylquinone were formed in LDL by the end of
incubation with cells (not shown). Stoichiometry between changes in
CEOOH and TOH levels was not consistent between experiments and varied
from 1:1 to 6.7:1 in 16 independent experiments with the mean 3.5 ± 1.6. Loss of CEOOH in LDL during incubation with cells (Fig. 1 and
2A) was accompanied by
formation of the corresponding hydroxides (CEOH), but this was not
stoichiometric (Fig. 2C). The amount of CEOH formed by the
end of incubation of LDL with cells was on average 42.5 ± 18.5%
of loss of CEOOH (mean ± S.D. from 16 independent experiments),
with the lowest and highest values being, respectively, 7.5 and 72%.
Analysis of cholesteryl keto-octadecadienoate (CE=O), another product
of hydroperoxide metabolism, in media samples demonstrated formation of
this product in the presence of cells but not in cell-free controls
(Fig. 2D). However, the amount of CE=O accumulated in LDL
during its incubation with cells was severalfold less than amount of
CEOOH lost in LDL (Fig. 2, A and D). Statistical
analysis of data from six experiments in which this lipid was analyzed demonstrated that average accumulation of CE=O was 9.8 ± 6.1% of
loss of CEOOH in LDL. In a separate experiment we studied stability of
the CEOH in LDL in the presence of cells to examine the possibility that CEOH undergo further cell-mediated metabolism. Mildly oxidized LDL
prepared as described under "Materials and Methods" was treated with NaBH4 to reduce chemically all hydroperoxides to the
corresponding hydroxides. After removal of non-reacted
NaBH4 by gel filtration of LDL through two sequential PD-10
columns, the LDL was mixed with DMEM (100 µg/ml) and incubated with
4 × 106 MPM for 2.5 h. No changes in the
concentration of LDL CEOH, as well as all other lipids assessed, were
observed at the end of the incubation (not shown, results are
reproducible in two separate experiments each run in triplicate),
suggesting that CEOH in LDL was stable in the presence of cells. These
results indicate that cell-mediated loss of CEOOH in LDL seen in DMEM
could not be completely explained by its stoichiometric reduction to
CEOH or CE=O.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 1.
Time and cell number dependence of LDL CEOOH
(A and B) and TOH (C
and D) loss by MPM. A and
C, LDL was incubated in DMEM (100 µg/ml) in the presence
of 2 × 106 MPM ( ) or in cell-free wells ( ) for
the times indicated. B and D, LDL in DMEM was
incubated for 2 h in cell-free wells or in the presence of the
indicated numbers of MPM. The levels of FC and CE remained unchanged
under all conditions. Values are expressed as nmol/mg LDL protein and
are means ± S.D. for triplicate wells and are from one experiment
representative of two.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 2.
Loss of CEOOH (A) and TOH
(B) was not accompanied by stoichiometric formation of
corresponding hydroxide (C) or cholesteryl
keto-octadecadienoate (D). LDL was incubated in
DMEM in the presence of 4 × 106 MPM (open
bars) or in cell-free wells (hatched bars). The levels
of FC and CE in LDL remained unchanged (not shown). Values are
expressed as nmol/mg LDL protein and are means ± S.D. for
triplicate wells.
|
|
To study whether the observed loss of TOH in LDL in the presence of
cells could be explained by a transfer of TOH from LDL to cells, we
analyzed both cellular lipid extracts and LDL lipid extracts before and
after incubation of LDL with cells. The basal level of TOH in MPM
plated at 4 × 106 was 3.26 ± 0.26 pmol/well
(mean ± S.D. for triplicate cultures). After 2 h incubation
with LDL cellular TOH levels increased to 4.86 ± 0.63 pmol/well,
and the concentration of TOH in LDL decreased from 8.1 ± 0.7 nmol/well to 4.1 ± 0.1 nmol/well (mean ± S.D.). The fact
that TOH loss in LDL exceeds by 250-fold the increase in cellular TOH
content during their incubation, together with our earlier data on the
stability of TOH content in macrophages incubated in the absence of LDL
(12), indicates that loss of TOH in LDL under our experimental
conditions could not be accounted for by its selective transfer to cells.
Incubation of MPM with LDL in the different metal ion-free medium,
HBSS, also resulted in reduction in CEOOH level (not shown). The rate
of CEOOH disappearance in LDL in HBSS was 1.9 ± 0.2 times lower
than in DMEM (mean ± range of two separate experiments). Similarly to DMEM, levels of FC or CE in LDL incubated with cells in
HBSS remained unchanged (not shown). We demonstrated that the different
capacity of cells to reduce levels of CEOOH in the two different media
could not be explained by the presence of phenol red in DMEM (264.9 mg/liter) and its absence in HBSS (not shown), and the reason for
different cellular activity to clear LDL CEOOH in the two media was not
further investigated in this study.
To test whether the observed clearance of LDL lipid hydroperoxides by
cells was specific for mouse peritoneal macrophages, we performed
similar experiments with human monocyte-derived macrophages (hMDM) and
murine macrophage-like J774 cells. As shown in Table I, incubation of 4 × 106 hMDM or 2.5 × 106 J774 cells with LDL
(100 µg/ml) in DMEM resulted in approximately 50% loss of CEOOH in
LDL after 2.5 h, with no changes in hydroperoxides seen in
cell-free incubations. Levels of FC and CE in LDL remained unchanged in
the presence or absence of cells. Peritoneal macrophages from C57BL/6J
mice were also able to decrease the level of CEOOH in LDL (data not
shown).
View this table:
[in this window]
[in a new window]
|
Table I
Human MDM and murine J774 cells reduce level of CEOOH in LDL incubated
in DMEM
LDL (100 µg/ml) was incubated in DMEM with 4 × 106 hMDM
or 2.5 × 106 J774 cells (+cells) or in cell-free wells
(CF) for 2.5 h. The levels of FC and CE remained unchanged. The
values are expressed as nmol/mg LDL protein and are means ± S.D.
for triplicate wells. The data are from one typical experiment out of
three for each cell type.
|
|
Incubation of Cell-conditioned Medium from Macrophages with LDL
Results in Reduction of the CEOOH Content of LDL--
To investigate
whether the observed activity of cells to reduce level of CEOOH in LDL
is an integral cellular activity or is secreted from cells, we studied
changes in lipid composition in LDL during its incubation in
cell-conditioned medium. Table II
demonstrates that cell-conditioned medium possessed a similar capacity
to remove lipid hydroperoxides in LDL to that of cells. Loss of CEOOH
in LDL incubated in cell-conditioned medium was accompanied by increase
in the level of corresponding hydroxides, and CE=O was formed in trace
amounts by the end of incubation (Table II). Similar to the
cell-containing condition, incubation of LDL with cell-conditioned
medium resulted in loss of TOH in LDL (Table II) without formation of
detectable amount of tocopherylquinone (not shown). No changes were
observed in the levels of FC and CE under this condition (not shown).
In cell-free control incubations lipid composition of LDL remained
unchanged (Table II). Analysis of stoichiometry between the loss of
CEOOH and the formation of CEOH in LDL incubated with cell-conditioned
medium in 25 independent experiments revealed that the amount of CEOH
formed was on average 71.4 ± 30.1% of the amount of CEOOH
degraded (mean ± S.D.) (the experiment in Table II being one with
the lower value). Dilution of cell-conditioned medium with
Chelex-treated PBS led to a decrease in its efficiency to decrease the
content of CEOOH in LDL; 2.4 times less CEOOH (10.7% of the initial
level of CEOOH in LDL) were degraded in LDL incubated for 2 h in 1 to 1 diluted cell-conditioned medium compared with undiluted
cell-conditioned medium (25.5% loss of the initial CEOOH level). We
determined that the activity of cell-conditioned medium to clear CEOOH
in LDL was stable for at least 3 h, if the medium was kept at
+4 °C (not shown).
View this table:
[in this window]
[in a new window]
|
Table II
Cell-conditioned medium possessed a similar capacity to remove LDL
lipid hydroperoxides compared with cells
LDL (100 µg/ml) was incubated in DMEM in the presence or absence of
4 × 106 MPM or in cell-conditioned medium for 2 h,
and the changes in levels of CEOOH, CEOH, CE=O, and TOH in medium were
analyzed. Values are expressed as nmol/mg LDL protein and are mean ± S.D. for triplicate wells. The initial levels of CEOOH, CEOH, CE=O,
and TOH in the mixture of DMEM and LDL prior to incubation were,
respectively, 17.8 ± 0.5, 12.6 ± 0.1, 0.1 ± 0.1, and
8.1 ± 0.7 nmol/mg LDL protein. Results are from one experiment.
The activity of cell-conditioned medium to reduce level of CEOOH in
different experiments varied from 54.8 to 159.2% of that by cells
(96.9 ± 32.9, mean ± S.D., n = 12) and to
reduce level of TOH from 69.9 to 152.9 (97.9 ± 33.2, n = 5).
|
|
We next studied the kinetics of LDL CEOOH loss in cell-conditioned
medium. In contrast to the almost linear cell-mediated loss of CEOOH
(Fig. 1A), disappearance of CEOOH in LDL in cell-conditioned medium had a biphasic character; the first fast stage normally finishing by 5-10 min after the start of incubation followed by a slow
stage of almost linear CEOOH degradation. During the fast stage almost
64.4 ± 15.1% (mean ± S.D. of six independent experiments) of the total loss of CEOOH in LDL occurred, with the remaining
35.6% being degraded over more than 2 h. The kinetics of TOH loss in LDL incubated in cell-conditioned medium had a similar pattern
to that of CEOOH loss in this condition; 59.6 ± 16.9% of total
loss of LDL TOH was observed within the first 5-10 min.
Similarly to the cell-conditioned medium from MPM, loss of CEOOH in LDL
was observed during incubation of LDL in the medium conditioned from
hMDM or from J774 cells. The average activity of the corresponding
cell-conditioned media to degrade CEOOH was 85.2 ± 8.4% that of
hMDM (mean ± S.D. of three experiments) and 92.1 ± 47.1%
of the activity of J774 (mean ± S.D. of five experiments).
To understand better the mechanism underlying the loss of CEOOH in the
presence of cell-conditioned medium, we synthesized [3H]Ch18:2-OOH and performed experiments on the
metabolism of the tracer. In the first series of experiments we
attempted to incorporate [3H]Ch18:2-OOH into LDL using
the method previously described for labeling of HDL3 with
[3H]Ch18:2-OOH incorporated into unilamellar donor
liposomes (8) with the reisolation of LDL as described (17).
Preliminary experiments on the incorporation of non-radiolabeled
Ch18:2-OOH into LDL demonstrated that a significant proportion of
Ch18:2-OOH in liposomes was converted into the corresponding hydroxide
during this procedure, so that the ratio of Ch18:2-OOH to Ch18:2-OH in
the resultant LDL was between 0.68 and 0.71 as compared with 14.5-26.1
in preparations of the freshly made donor liposomes. The amount of
Ch18:2-OOH incorporated into LDL was on average 20.9%
(n = 3) of its levels in the liposomes. Due to this
very low recovery of Ch18:2-OOH and high conversion to Ch18:2-OH in the
resulting LDL in addition to the high cost of the synthesized
[3H]Ch18:2-OOH, it was decided to perform further
experiments with the tracer incorporated into liposomes rather than
LDL.
Incubation of unilamellar liposomes containing DMPC, FC,
-TOH,
Ch18:2-OOH, and [3H]Ch18:2-OOH (specific activity in
liposomes 0.05 Ci/mmol) with cell-conditioned medium from MPM for
2.5 h resulted in a 15.1 ± 3.8% decrease in the level of
[3H]Ch18:2-OOH. No loss of total radioactivity per sample
was detected. A small decrease in
-TOH level (10.3%) and no change
in FC level were observed. The loss of [3H]Ch18:2-OOH in
the presence of cell-conditioned medium was accompanied by an increase
of the amount of [3H]Ch18:2-OH, which accounted for
65.8% of [3H]Ch18:2-OOH consumed under this condition.
This supports our early results that the major product accompanying
loss of CEOOH in the presence of cell-conditioned medium is the
corresponding hydroxide. No [3H]cholesterol was detected
in the lipid extract, indicating that the loss of CEOOH in the
cell-conditioned medium could not be explained by the hydrolysis of the
ester with formation of FC and a free fatty acid hydroperoxide. No
other well defined peaks containing the tracer were observed in the
lipid extract under the used chromatographic conditions. The remaining
loss of Ch18:2-OOH, not accounted for by the formation of Ch18:2-OH,
could be partially explained by the slight, although not statistically
significant, increase in the levels of two other products which, using
HPLC conditions described under "Materials and Methods," elute very close to [3H]Ch18:2-OOH and [3H]Ch18:2-OH.
These peaks with the retention times 11.5 and 18.8 min, as compared
with 14.4 and 15.9 min for [3H]Ch18:2-OOH and
[3H]Ch18:2-OH, respectively, form shoulders on the tails
of the peaks corresponding to the two major oxidized products of
[3H]Ch18:2. The products have a maximum of absorbance
close to 235 nm (like the major peaks) and are sensitive to
NaBH4. Their further characterization was not performed in
this study, but they may include various positional and regio-isomers
of oxidation products of Ch18:2 and/or adduct(s) with TOH. We expect
that additional information on the products of Ch18:2-OOH degradation
mediated by cells or cell-conditioned medium could be obtained with the use of cholesteryl-[14C]linoleate. However, this compound
is not commercially available, and we were unable to pursue the
investigation in this direction further.
Investigation of the Involvement of Metal Ions in Cell-mediated
Loss of CEOOH and TOH in LDL--
In the presence of traces of
transition metals, decomposition of CEOOH could occur via a Fenton-type
reaction. To study the possible involvement of the metals that might
derive from cells or be present in trace amounts in the culture medium,
we performed a series of experiments with metal chelators. These were
as follows: BCS, a high affinity chelator for Cu(I), the iron-selective
chelator desferal (DF), EDTA, and DETAPAC which efficiently bind both
iron and copper ions. Addition of any of these chelators to cell
culture medium did not have significant effect on loss of CEOOH in LDL during its incubation with MPM (Table
III). Cellular viability (assessed by a
trypan blue test) was not affected by the presence of the indicated
amounts of a chelator in medium (not shown). Loss of CEOOH in LDL
incubated with cell-conditioned medium also was not significantly
affected by the presence of any of the metal chelators used (Table
III). We also measured free copper in the medium before and after
incubation with cells using the BCS-ascorbate assay. No copper was
detected in cell culture medium by this method, which has a detection
limit of approximately 0.4 nM copper (I). No significant
effect of the chelators was observed on loss of CEOOH mediated by J774
cells or cell-conditioned medium from these cells (data not shown).
View this table:
[in this window]
[in a new window]
|
Table III
Metal chelators do not have a significant effect on degradation of
CEOOH in LDL by cells or cell-conditioned medium
LDL (100 µg/ml) was incubated in DMEM with cells or in
cell-conditioned medium in the presence or absence of a chelator for
2.75 h in the experiments with BCS and for 2 h in the
experiments with DF, DETAPAC, EDTA, and NaCN. Values are means ± S.D. for triplicate incubations from a single experiment for each
condition. Cellular experiments with or without DF, DETAPAC, and NaCN
were performed twice with results being reproducible.
|
|
In another series of experiments, we compared the degree of CEOOH
degradation by cells in DMEM that was pretreated with Chelex-100 resin
(3 g/1 liter, for 18 h) to remove any contaminating transition metals versus untreated DMEM. When 4 × 106
MPM were incubated with 100 µg of LDL in Chelex-treated DMEM, the
loss of CEOOH observed after 2 h was 99.7 ± 25.6%
(mean ± S.D. of four independent experiments) of that seen during
incubation of LDL with cells in not Chelex-treated DMEM. This indicates
that there was no inhibitory effect of preincubation of medium with Chelex on cell-mediated CEOOH degradation.
We also investigated whether cell-derived heme in hematoproteins or
heme-containing enzymes is responsible for cell-mediated loss of CEOOH
in LDL. Addition of 200 µM of the heme-ligand, sodium cyanide (NaCN), to cell-conditioned medium from J774 cells did not have
a significant effect on CEOOH degradation (Table III). Neither did
cyanide affect loss of LDL CEOOH in the presence of the cells (Table
III).
These results suggest that the loss of LDL lipid hydroperoxides
observed in the presence of cells or in cell-conditioned medium is
unlikely to be a free metal ion- or heme-catalyzed process.
LDL CEOOH Loss in Cell-conditioned Medium Is Inhibited by Heat
Treatment of the Medium and Is Associated with Its High Molecular
Weight Components--
We investigated the component(s) of
cell-conditioned medium responsible for loss of CEOOH in LDL. First,
sensitivity of this component(s) to heat treatment was studied.
Incubation of an aliquot of cell-conditioned medium at 60 °C for 30 min prior to mixing with LDL (100 µg/ml) resulted in a 65.5% (mean
from two experiments) reduction in LDL lipid hydroperoxide clearance
during 2 h incubation in comparison with control, not
heat-treated, cell-conditioned medium. Boiling of cell-conditioned
medium at 100 °C for 5 min led to loss of 88% of
hydroperoxide-reducing activity of cell-conditioned medium (mean from
two experiments). These results suggest involvement of a heat-labile
component, possibly protein, secreted by cells in the clearance of
CEOOH from LDL.
To investigate further the possible involvement of a protein in
degradation of CEOOH in LDL, we subjected cell-conditioned medium to
filtration through a Centricon-10 unit, which allows separation of
components with molecular mass above and below 10,000 Da. Results
presented in Table IV demonstrate that
the high molecular weight (HMW) fraction of cell-conditioned medium
retained the capacity to reduce levels of CEOOH and TOH in LDL, whereas
the low molecular weight (LMW) fraction virtually lacked activity to
degrade CEOOH and had 2.4 times lower activity to reduce level of TOH
as compared with original cell-conditioned medium. Although cell-derived HMW components had a high activity to clear LDL lipid hydroperoxides, 100% recovery of the initial activity was not reached.
Combining HMW and LMW fractions of cell-conditioned medium did not
result in increased CEOOH-degrading capacity compared with HMW fraction
alone (not shown). This could be possibly due to the loss of some
activity during filtration or absorptive losses in the Centricon
unit.
View this table:
[in this window]
[in a new window]
|
Table IV
Activity of cell-conditioned medium to reduce levels of CEOOH and TOH
is likely associated with its high molecular weight fraction
Cell-conditioned medium was filtered through Centricon-10 unit and high
and low molecular weight fractions were reconstituted to the original
volume with DMEM, mixed with LDL (100 µg/ml), and incubated for
2.5 h at 37 °C. Values are means ± S.D. for triplicate
extractions and are from one typical experiment out of three.
|
|
Proteins and LMW components of cell-conditioned medium were also
separated by gel filtration through a PD-10 column. Fig. 3 demonstrates that the first 3-ml
fraction (denoted as I), eluted from the column after
loading 3 ml of cell-conditioned medium and equivalent to the excluded
components with mass >25 kDa, had the highest activity to reduce level
of CEOOH in LDL as compared with two other consecutively eluted 3-ml
fractions (II and III). The first fraction also
had a high activity to degrade LDL TOH, similar to that in the original
cell-conditioned medium, whereas this activity in two other fractions
was accordingly 4.3 and 4.8 times lower than in the fraction I.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 3.
Activity of cell-conditioned medium to reduce
levels of CEOOH (A) and TOH (B) is
more likely associated with its high molecular weight fraction.
Three-ml aliquot of cell-conditioned medium (obtained from incubation
of DMEM with 4 × 106 MPM for 2.5 h) was filtered
through PD-10 column equilibrated with DMEM, and three consecutively
eluted fractions (I, II, and III, 3 ml each) were
mixed with LDL (100 µg/ml) and incubated for 2.5 h. Levels of
CEOOH and TOH in LDL before incubation as well as after 2.5 h
incubation in cell-free DMEM (CF) and in cell-conditioned
medium (c/c) are also presented. Values are expressed as
nmol/mg LDL protein and are means ± S.D. for triplicate
incubations from a single experiment.
|
|
The treatment of the cell-conditioned medium with trypsin (10 µg/ml)
for 15 min at 37 °C prior to mixing it with LDL did not result in
the inhibition of the ability of cell-conditioned medium to reduce the
level of CEOOH in two independent experiments (data not shown). We also
investigated the pH dependence of the activity of cell-conditioned
medium to decrease the level of CEOOH in LDL. Aliquots of freshly
collected cell-conditioned medium with pH 7.8 were adjusted to pH 5, 6, or 7 with the citrate/phosphate buffer or to pH 9 with the Tris buffer
and mixed with LDL (100 µg/ml). The loss of LDL CEOOH observed after
2.5 h incubation did not vary significantly between the different
conditions in two independent experiments (data not shown), indicating
that there was no clear pH optimum for the activity of cell-conditioned medium to reduce the level of CEOOH in LDL in the pH range between 5 and 9, consistent with the involvement of a non-enzymatic factor in
this process.
Thus, the association of the activity of cell-conditioned medium to
decrease the LDL levels of hydroperoxide and TOH with its high
molecular weight fraction (greater than 10,000 Da) together with the
loss of this activity after heat treatment suggest involvement of a
protein in this reaction. The absence of the effect of trypsin on this
activity possibly indicates that the treatment with trypsin under the
used conditions leaves the reactive center on the protein intact.
Importance of Thiols for Cell-mediated CEOOH Degradation in
LDL--
Among cellular metabolites, thiols have been implicated in
peroxide detoxification; they are essential cosubstrates for
enzyme-catalyzed detoxification of various peroxides (23) and can
directly reduce various biological molecules (24), including
hydroperoxides (9, 25). Decomposition of peroxides could also occur via thiol-driven Fenton reactions in the presence of traces of transition metals, although the latter seem to be unlikely under the conditions of
this study (as shown above). It has been demonstrated that cells
release sulfhydryl compounds into the medium and can reduce extracellular disulfides such as protein disulfides or cystine (22,
26-28). Cells can utilize extracellular cystine to produce cysteine
(26, 27, 29) which upon release into the medium can generate sulfhydryl
groups on proteins via sulfhydryl-disulfide exchange reactions (26,
28); this implicates cystine as an intermediate in protein disulfide reduction.
To investigate the relevance of thiols in the process of cell-mediated
CEOOH clearance, we compared the efficiency of CEOOH degradation in
cell-conditioned medium before and after treatment with
N-ethylmaleimide (NEM). Addition of 100 µM
NEM, an agent commonly used to block free thiol groups, to
cell-conditioned medium resulted in approximately 65% inhibition in
CEOOH degradation, confirming thiol importance (Fig.
4A). No effect of NEM was
observed on the level of CEOOH (Fig. 4A) and other LDL
lipids (not shown) in cell-free incubations in the original DMEM.
Similar inhibitory action of NEM on loss of CEOOH in LDL was observed
in cell-conditioned medium from human monocyte-derived macrophages
(Fig. 4B). Pretreatment of mildly oxidized LDL (1.9 mg/ml)
with 4 mM NEM for 1 h on ice followed by removal of
NEM by gel filtration through a PD-10 column did not affect the ability
of cells to decrease the level of CEOOH in this LDL compared with
untreated LDL (not shown). This suggests that thiol groups on apoB in
LDL do not play a significant role in cell-mediated degradation of LDL
CEOOH.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 4.
NEM diminishes CEOOH clearance in LDL in
cell-conditioned medium from 4 × 106 MPM
(A) or 1 × 106 hMDM
(B). LDL was incubated for 2.5 h in
cell-conditioned medium in the presence or absence of NEM (100 µM in A and 400 µM in
B) or in cell-free wells (CF). Values are
expressed in nmol/mg LDL protein and are means ± S.D. for
triplicate incubations from a typical experiment out of two for each
cell type.
|
|
We then tested whether the presence of cystine, a low molecular weight
disulfide, in DMEM has an effect on cell-mediated CEOOH degradation,
particularly because of its capacity to act as an intermediate in
protein disulfide reduction. MPM incubated with LDL in DMEM containing
cystine degrade approximately 3.4 times more CEOOH during 2.5 h
than cells incubated in the cystine-deprived medium (Fig.
5A). The level of CEOOH in LDL
remained unchanged in LDL incubated without cells regardless of the
presence of cystine in the medium (Fig. 5A). Cell-mediated
loss of TOH in LDL was also accelerated by the presence of cystine in
the medium (Fig. 5B), with no changes in TOH concentration
detected in cell-free conditions (Fig. 5B). The efficiency
of cell-conditioned medium to reduce the level of CEOOH in LDL also
depended on the presence of cystine during conditioning: 52.5 ± 0.8% of LDL CEOOH were lost during 2.5 h incubation of LDL (100 µg/ml) in cystine-containing cell-conditioned medium
versus 17.5 ± 1.06% in cystine-deprived cell-conditioned media, which were prepared by preincubation of 4 × 106 cells with, respectively, cystine containing or
deprived DMEM for 2.5 h. These results indicate that the presence
of cystine in the culture medium facilitates degradation of CEOOH in
LDL by cells or cell-conditioned medium.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of L-cystine on CEOOH
(A) and TOH (B) loss in LDL. LDL
(100 µg/ml) was incubated for 2.5 h in DMEM with
(+Cys) or without ( Cys) cystine (200 µM) in the presence of 4 × 106 MPM or
in cell-free wells. Values are expressed in nmol/mg LDL protein and are
means ± S.D. for triplicate incubations from a single experiment.
The mean ± S.D. of CEOOH reducing activity of cells in
( Cys)-DMEM in five experiments was 56.5 ± 26.5% that in
(+Cys)-DMEM.
|
|
Previous reports have shown that several cell types, including
macrophages, can utilize cystine from the medium to produce extracellular low molecular weight thiols (22, 26, 27), predominantly
cysteine, and release of low amounts of glutathione (GSH) has also been
suggested (27). We tested the potential involvement of such thiols in
degradation of CEOOH in LDL by incubating LDL in cell-free DMEM in the
presence of reduced glutathione or cysteine in the range of
concentrations reported for thiols exported by macrophages (22, 27).
The level of CEOOH in LDL remained unchanged after its incubation in
DMEM containing 5, 10, or even 20 µM of either thiol for
2.5 h, suggesting that at these concentrations the low molecular
weight thiols are not directly responsible for cell-mediated
degradation of LDL CEOOH. This agrees with the results presented above
that low molecular weight components of cell-conditioned medium are
inefficient in mediating loss of CEOOH in LDL. However, when 10 µM reduced glutathione was added to the cell-conditioned medium incubated with LDL, the loss of CEOOH increased by an additional 11.6%. From these results we can suggest that the stimulatory effect
of cystine on CEOOH degradation by cells or cell-conditioned medium was
probably due to its reported capacity to enhance generation of
extracellular protein thiols (26, 28), which have been shown to be more
resistant to autoxidation than free low molecular weight thiols (26,
28). The stimulatory effect of GSH on LDL CEOOH degradation seen in
cell-conditioned medium could be explained by the same mechanism. Since
the high molecular weight fraction of the cell-conditioned medium has
the greatest ability to decrease levels of CEOOH, it is most likely
that protein sulfhydryl groups are important for cell-mediated CEOOH clearance.
Thus, the inhibitory effect of NEM on clearance of LDL CEOOH in
cell-conditioned medium demonstrates the involvement of thiols in the
extracellular cell-mediated detoxification of LDL lipid hydroperoxides.
Low molecular weight thiols generated by cells are unable to mediate
directly extracellular loss of CEOOH in LDL, perhaps due to their very
low levels, and the stimulatory effect of cystine in cell culture
medium on CEOOH degradation by cells or cell-conditioned medium may be
explained by its enhancement of secreted protein thiol content in the system.
The Involvement of TOH in LDL in Cell-mediated CEOOH
Degradation--
As been shown earlier (Figs. 1-3 and 5 and Table
IV), one of the features of cell-mediated loss of CEOOH in LDL is the
accompanying decrease of its TOH level. Factors that affected CEOOH
degradation also influenced the loss of TOH. To determine the
relationship between the loss of TOH and CEOOH, we studied the
stability of CEOOH in LDL that was depleted of TOH (denoted as
(
TOH)LDL) but that contained CEOOH at levels comparable to that in
preoxidized TOH-containing LDL (denoted as (+TOH)LDL). The ability of
MPM to degrade CEOOH was significantly impaired in LDL depleted of TOH.
After 2 h incubation of LDL with MPM plated at a density between
1 × 106 and 4 × 106, the level of
CEOOH remained unchanged in (
TOH)LDL, whereas cell
number-dependent loss of hydroperoxides was observed in
(+TOH)LDL with all hydroperoxides being lost in incubations with 3 × 106 and 4 × 106 MPM (Fig.
6). No significant CEOOH degradation in
either LDL was observed in cell-free conditions (not shown). It should
be noted that in some experiments a small loss of CEOOH in (
TOH)LDL during its incubation with 4 × 106 MPM was observed;
however, degradation of CEOOH in (
TOH)LDL was on average 31.5 ± 34.6% (mean ± S.D.) that in (+TOH)LDL in six independent
experiments.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 6.
Cell-mediated loss of CEOOH in ( TOH)LDL and
(+TOH)LDL. TOH-containing or TOH-depleted LDL were incubated for
2 h in the absence or in the presence of different number of MPM.
Values are expressed as nmol/mg LDL protein and are means ± S.D.
for triplicate wells from a single experiment.
|
|
To test whether decreased CEOOH clearance in (
TOH)LDL was due to the
absence of TOH, rather than some other unidentified changes in LDL
occurring during its preparation, we performed a series of experiments
in which (
TOH)LDL was replenished with TOH (denoted as (
/+TOH)LDL)
using the procedure described under "Materials and Methods." We
demonstrated that incubation of (
TOH)LDL or (+TOH)LDL with LPDS at
37 °C for 4 h, which is a feature of the replenishment
procedure, did not affect the level of subsequently reisolated LDL
CEOOH and kinetics of their degradation by cells (not shown).
Replenishment of (
TOH)LDL with TOH restored its capacity to decrease
the level of endogenous CEOOH in the presence of cells, influencing
both the kinetics of the reaction (the loss of half of the initial
amount of CEOOH in (+TOH)LDL, (
TOH)LDL, and (
/+TOH)LDL was achieved
correspondingly after 1.5, 3, and 1.5 h of incubation in a single
experiment) and the total loss of CEOOH detected after 3 h of
incubation (Table V). These results indicate that TOH in LDL is an important component in the process of
cell-mediated clearance of LDL CEOOH.
View this table:
[in this window]
[in a new window]
|
Table V
Cell-mediated loss of CEOOH in ( TOH)LDL replenished with TOH is
similar to that in (+TOH)LDL and is higher than in TOH-depleted LDL
4 × 106 MPM were incubated in 1 ml of DMEM in the
presence of 100 µg of TOH-containing, TOH-depleted, or
TOH-replenished LDL (denoted accordingly, as (+TOH)LDL, ( TOH)LDL, and
(±TOH)LDL) for 3 h. Values are means ± range for two
independent experiments run in triplicate.
|
|
 |
DISCUSSION |
It is generally accepted that among events contributing to the
development of atherosclerosis oxidation of LDL plays an important role
(1, 2). The cells present in the arterial intima and developing lesions
(macrophages, monocytes, smooth muscle cells, endothelial cells, and
leukocytes) can oxidatively modify LDL in vitro (1, 3),
although the precise mechanism(s) of cell-mediated LDL oxidation are,
as yet, incompletely understood. Despite the numerous studies aimed to
investigate the pro-oxidant and therefore potential proatherogenic
action of cells of the arterial wall toward LDL, little attention has
been attracted to the possible antioxidant role of the cells. One
approach to investigate preventative action of cells in relation to
lipoprotein oxidation has been to study the effect of antioxidant
status of cells on their ability to oxidize LDL (12, 30). However, as
we have recently demonstrated, increased
-TOH content of macrophages
does not influence kinetics of lipoprotein oxidation by these cells
in vitro (12). Reports in the literature indicate that under
certain conditions macrophages and endothelial cells could inhibit
lipid oxidation in LDL (5-7), one of the suggested mechanisms being
sequestration of metals from the culture medium (5). It has been
demonstrated that human hepatic cells could play a potentially
protective role by selectively removing and detoxifying cholesteryl
ester hydroperoxides from high density lipoprotein (8). We have
recently reported that murine macrophages could rapidly remove
peroxides from oxidized amino acids, peptides, and proteins (9), the
process which, at least in the case of proteins, is likely to be
predominantly extracellular. In this paper we demonstrated for the
first time the ability of human and murine macrophages to reduce level
of cholesteryl ester hydroperoxides in LDL, thus potentially decreasing further deleterious oxidative modifications to the lipoprotein.
We demonstrated that incubation of mouse peritoneal macrophages with
LDL containing modest levels of CEOOH (up to 40 nmol/mg LDL protein),
but otherwise without significant changes in its protein and lipid
composition, in the medium not permissive for LDL oxidation (DMEM or
HBSS) resulted in substantial loss of lipoprotein CEOOH within 2-3 h.
This process was time-dependent, and loss of CEOOH
increased with increase of number of cells in culture. A reduction of
CEOOH level in LDL was also seen in the presence of murine J774
macrophages and human monocyte-derived macrophages, indicating that
this activity was not specific for mouse peritoneal macrophages (from
both QS and C57BL/6J mice). It is noteworthy that the levels of
oxidized cholesteryl linoleate (in mmol/mol of Ch18:2), the most
abundant cholesteryl ester in LDL, used in this study were comparable
with those determined in LDL fractions from advanced human
atherosclerotic plaques (31), the difference being that in mildly
oxidized LDL used here the major oxidized product of Ch18:2 was its
hydroperoxide derivative, whereas in advanced plaques more than
two-thirds of the oxidized lipid is present in the form of the
hydroxide (31).
In the course of investigating of mechanisms underlying cell-mediated
loss of CEOOH in LDL, we demonstrated that transition metal ions were
not likely to play an important role in this process. Although very low
amounts (0.2 µM) of Fe(III) are present in DMEM, according to the manufacturer's specification, and cells potentially are able to extracellularly reduce oxidized transition metal (6, 22),
this reaction does not seem to contribute to LDL lipid hydroperoxide
decomposition by cells. This is based on our finding that loss of CEOOH
was not affected by the pretreatment of culture medium with Chelex
resin. The lack of effect of high affinity metal chelators (DF, BCS,
EDTA, and DETAPAC), both in the presence of cells and in
cell-conditioned medium, indicates that degradation of CEOOH was
unlikely to be mediated by cell-derived free or protein-bound metal
ions. Moreover, it is well established that in the presence of low
concentrations of transition metals cells rather promote LDL
oxidation (4, 22, 32), and increased levels of preformed lipid
hydroperoxides in LDL usually facilitate oxidative processes in the
lipoprotein (7, 33-36). The oxidation of LDL mediated by cells is
characterized by loss of cholesteryl esters and accumulation of
significant amounts of CEOOH at early stages, followed by formation of
oxysterols, e.g. 7-ketocholesterol, at more advanced stages of LDL oxidation (19, 37). No such changes were observed during incubation of LDL with cells in this study, supporting our conclusion of metal ion-independent degradation of CEOOH mediated by cells in DMEM
or HBSS. Involvement of cell-derived heme in cell-mediated loss of
CEOOH was also excluded as heme-chelator sodium cyanide failed to
affect the reaction.
The ability of cell-conditioned medium to reduce the level of CEOOH in
LDL similarly to cells allows us to exclude several potential
mechanisms in playing the major role in macrophage-mediated clearance
of lipid hydroperoxides in LDL. The latter could not be attributed to
the cellular uptake of whole lipoprotein particles, which is also
supported by the fact that levels of free cholesterol and cholesteryl
esters in the medium remained unchanged, or to the
endocytosis/retroendocytosis process. It is also unlikely to be due to
selective uptake of LDL CEOOH by macrophages, as has been demonstrated
for hepatic cells in relation to HDL CEOOH (8), since results with
cell-conditioned medium indicate that the activity of cells to reduce
the concentration of CEOOH in LDL is not an integral component of the
cell but is secreted from it. However, the possibility that the
activities predominantly responsible for CEOOH clearance by cells or by
cell-conditioned medium are different cannot be excluded. Supporting
this is the different efficiency of conversion of CEOOH to CEOH in
these two systems, i.e. 42.5 versus 71.4% on
average. The loss of the activity to decrease the level of CEOOH in LDL
after heat treatment of cell-conditioned medium and its association
with high molecular weight component(s) indicate that the secreted
factor mediating CEOOH degradation in LDL is likely to be a protein.
Among known cell-derived proteins able to detoxify lipid
hydroperoxides, a representative of selenium-dependent
glutathione peroxidase family, phospholipid hydroperoxide glutathione
peroxidase, has been shown to reduce cholesterol ester hydroperoxides
in oxidized LDL in vitro (38, 39). However, to our knowledge
there have been no reports on the existence of a secreted form of this
enzyme. Moreover, reduction of CEOOH by phospholipid hydroperoxide
glutathione peroxidase resulted in formation of equimolar amounts of
the corresponding hydroxides and did not affect the TOH level in LDL
(39), whereas cell-mediated degradation of CEOOH in LDL reported in our
study was accompanied by the consumption of TOH in LDL, and CEOH,
although being the major product of CEOOH degradation, could not
account for all CEOOH loss. This argues against the involvement of a
peroxidase as a sole player in cell-mediated loss of LDL lipid
hydroperoxides. The enzyme thioredoxin reductase has been demonstrated
to be able to reduce directly some lipid hydroperoxides to the
corresponding alcohol (40). However, because of the absence of
equimolar accumulation of CEOH during cell-dependent CEOOH
loss, this enzyme was also unlikely to be solely responsible for the
CEOOH clearance by macrophages. Moreover, the absence of a clear pH
optimum for this activity is consistent with the involvement of a
non-enzymatic factor in this process. It has been recently reported
that apoB mediates reduction of lipid hydroperoxides, including
cholesteryl ester hydroperoxides (41). Although a role of apoB-100 in
the decrease of the level of CEOOH mediated by cells could not be
excluded, our results from experiments with liposomes incubated with
cell-conditioned medium, where the loss of Ch18:2-OOH was observed in
the absence of apoB, show that it is not required for CEOOH degradation
and suggest that some other cell-derived protein plays a role in this process. This activity was not due to contamination of LDL preparations with plasma glutathione peroxidase, as incubation of LDL with LPDS for
4 h did not result in a decrease in level of LDL CEOOH, in
agreement with early reports on lack of activity of plasma glutathione
peroxidase toward complex lipid hydroperoxides, including CEOOH (42).
Neither was this activity due to the possible contamination of LDL with
human serum albumin which as been reported recently is able to reduce
phospholipid hydroperoxides (43). In addition to the absence of 1 to 1 stoichiometry between changes in the levels of CEOOH and CEOH and
stability of CEOOH in LDL during its incubation with LPDS, this is
supported by our result that cysteine or glutathione added to the
cell-free incubation of LDL at the concentrations reported to be
secreted by macrophages does not promote CEOOH loss.
Cell-mediated loss of cholesteryl ester hydroperoxides in LDL could
hypothetically result from extracellular hydrolysis of cholesteryl
esters with release of oxidized free fatty acids and cholesterol. As
the masses of unoxidized cholesteryl esters and cholesterol in LDL
during its incubation with cells remained unchanged in this study, this
process does not seem to contribute to CEOOH degradation. Moreover,
hormone-sensitive lipase expressed in mouse peritoneal macrophages and
murine J774 macrophages (44-46) and responsible for hydrolysis of CE
in these cells is an intracellular enzyme, and we are unaware of any
reports on its secretion by cells. Cholesteryl ester hydrolase
synthesized in human monocyte-derived macrophages has been reported to
be secreted by the cells, but it is inactive in the absence of bile
salts (46). Preliminary results from our laboratory indicate that
cell-conditioned media from MPM or J774 cells lack neutral cholesteryl
ester hydrolase activity.3
However, the strongest argument against hydrolysis of oxidized cholesteryl esters as the mechanism for cell-mediated CEOOH loss in LDL
derives from the experiments with the radiolabeled Ch18:2-OOH. The
absence of the detectable amounts of [3H]cholesterol
during the incubation of cell-conditioned medium with
[3H]Ch18:2-OOH-containing liposomes excludes the
hydrolysis of the oxidized cholesteryl ester under these conditions.
The inhibition of the capacity of cell-conditioned medium to reduce
levels of CEOOH in LDL by NEM suggests that this process depends on the
availability of free thiol groups. As has been demonstrated earlier,
macrophages secrete low and high molecular weight thiols (22), and
thiol production significantly depends on the presence of cystine in
the culture medium (27, 22). LMW thiols are not directly responsible
for loss of CEOOH as was demonstrated by the inactivity of the LMW
fraction of cell-conditioned medium and the lack of effect of added GSH
or cysteine at relevant concentrations (22, 27) on CEOOH levels in
cell-free medium. However, they may contribute to the process by
providing reducing equivalents to a protein (26, 28). The latter could
also be mediated by thioredoxin, which could act either extracellularly (47) or in association with the cell surface (48); however, this was
not investigated in the present study. Protein-associated sulfhydryl
groups are more resistant to autoxidation than LMW thiols (26, 28) and
therefore may be present at levels necessary for CEOOH degrading
activity. Cystine in the culture medium probably helps to maintain the
required level of protein-bound thiols in the medium, thus explaining
its stimulatory effect on CEOOH degradation by cells or
cell-conditioned medium. This could be also the mechanism by which GSH
at concentrations not able to reduce directly CEOOH in cell-free medium
stimulates its loss when added to cell-conditioned medium. It has been
demonstrated that protein-associated thiols could determine folding of
proteins and their overall structure (49). They could also play a key
role in activation/inactivation of enzymes via rapid chemical
transformation of the mercapto group. Thiols could also directly
participate in the redox reactions with or without free radical formation.
-Tocopherol in LDL is an important component in reaction of CEOOH
degradation mediated by cells. This is based on the following results:
(i) reduction of CEOOH level in LDL was accompanied by the decrease in
concentration of TOH in lipoprotein, which is not associated with its
transfer to cells; (ii) factors that affected CEOOH degradation
similarly influenced loss of TOH; and most important (iii) CEOOH
degradation b